Company profile for Andelyn Biosciences

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Andelyn Biosciences is a partner to any organization working to improve human health, with scalable flexibility to adapt to our clients’ needs. A client partner might be a patient foundation searching for a cure. A Fortune 100 company starting Phase 3 trials. A university proposing an IND. Our state-of-the-art cGMP manufacturing facility – opening in 2022 – is capable of early-stage development through commercial scale p...
Andelyn Biosciences is a partner to any organization working to improve human health, with scalable flexibility to adapt to our clients’ needs. A client partner might be a patient foundation searching for a cure. A Fortune 100 company starting Phase 3 trials. A university proposing an IND. Our state-of-the-art cGMP manufacturing facility – opening in 2022 – is capable of early-stage development through commercial scale production.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
U.S.A
Address
Address
575 Children's Crossroad, Columbus, Ohio 43215
Telephone
Telephone
1-844-AAV-CDMO
youtube
YouTube
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

DCAT Week

DCAT Week

Not Confirmed

envelop Contact Supplier

DCAT Week

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.globenewswire.com/news-release/2025/11/17/3189051/0/en/Solid-Biosciences-Announces-Licensing-Agreement-with-Andelyn-Biosciences-for-the-Use-of-Proprietary-Next-Generation-Capsid-AAV-SLB101.html

GLOBENEWSWIRE
17 Nov 2025

https://www.prnewswire.com/news-releases/andelyn-biosciences-and-amplo-biotechnology-partner-to-manufacture-novel-gene-therapies-for-diseases-affecting-the-neuromuscular-junction-302535147.html

PR NEWSWIRE
21 Aug 2025

https://www.expresspharma.in/andelyn-biosciences-uses-aav-curator-platform-to-deliver-novel-gene-therapy-for-ultra-rare-nedamss-disease/

EXPRESS PHARMA
13 May 2025

https://www.contractpharma.com/breaking-news/andelyn-manufactures-novel-gene-therapy-for-ultra-rare-nedamss-disease-patient/

CONTRACTPHARMA
12 May 2025

https://www.contractpharma.com/breaking-news/andelyn-biosciences-manufactures-viral-vector-with-aav-curator-platform/

CONTRACTPHARMA
07 May 2025

https://www.andelynbio.com/news-media/andelyn-biosciences-selected-by-hubble-therapeutics-to-manufacture-clinical-grade-aav-for-the-treatment-of-leber-congenital-amaurosis-lca16

PRESS RELEASE
09 Oct 2024

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty